(Q38484968)

3 September 2017

title

Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma? (English)

1 reference

3 September 2017

Stallings RL

1

1 reference

3 September 2017

Howard J

2

1 reference

3 September 2017

Dunlop A

3

1 reference

3 September 2017

Mullarkey M

4

1 reference

3 September 2017

McDermott M

5

1 reference

3 September 2017

Breatnach F

6

1 reference

3 September 2017

O'Meara A

7

1 reference

3 September 2017

publication date

1 January 2003

1 reference

Cancer Genetics and Cytogenetics

3 September 2017

published in

1 reference

3 September 2017

volume

140

1 reference

3 September 2017

issue

2

1 reference

3 September 2017

page(s)

133-137

1 reference

Biology and genetics of human neuroblastomas.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900681-7

7 January 2021

Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900681-7

7 January 2021

Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900681-7

7 January 2021

Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900681-7

7 January 2021

Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900681-7

7 January 2021

Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900681-7

7 January 2021

Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900681-7

7 January 2021

Comparative genomic hybridization (CGH) analysis of neuroblastomas--an important methodological approach in paediatric tumour pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900681-7

7 January 2021

Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. U.K. Children's Cancer Study Group and the U.K. Cancer Cytogenetics Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900681-7

7 January 2021

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900681-7

7 January 2021

Cytogenetic and molecular study of two human neuroblastoma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900681-7

7 January 2021

Detection of MYCN amplification in three neuroblastoma cell lines by non-radioactive chromosomal in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900681-7

7 January 2021

Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900681-7

7 January 2021

1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900681-7

7 January 2021

Peripheral neuroblastic tumors: pathologic classification based on recommendations of international neuroblastoma pathology committee (Modification of shimada classification).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900681-7

7 January 2021

Molecular analysis of chromosome arm 17q gain in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900681-7

7 January 2021

10.1016/S0165-4608(02)00681-7

Identifiers

DOI

1 reference

3 September 2017

1 reference